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Summary
 
Interleukin (IL)-4 is the most potent factor that causes naive CD4
 
1
 
 T cells to differentiate to
the T helper cell (Th) 2 phenotype, while IL-12 and interferon 
 
g
 
 trigger the differentiation of
Th1 cells. However, the source of the initial polarizing IL-4 remains unclear. Here, we show
that IL-6, probably secreted by antigen-presenting cells, is able to polarize naive CD4
 
1
 
 T cells
to effector Th2 cells by inducing the initial production of IL-4 in CD4
 
1
 
 T cells. These results
show that the nature of the cytokine (IL-12 or IL-6), which is produced by antigen-presenting
cells in response to a particular pathogen, is a key factor in determining the nature of the im-
mune response.
 
I
 
n response to pathogens, naive CD4
 
1
 
 T cells differenti-
ate into effector Th1 and Th2 cells. Th1 cells produce
IL-2, IFN-
 
g
 
, and TNF-
 
b
 
, which are involved in cell-
mediated inflammatory reactions. Th2 cells secrete mainly
IL-4, IL-5, IL-6, IL-10, and IL-13, which mediate B cell
activation, antibody production, and the regulation of Th1
responses (for review see reference 1). In general, a Th1 re-
sponse helps eradicate intracellular microorganisms, whereas
a Th2 response can control extracellular pathogens. Devel-
opment of an inappropriate response can lead to ineffective
immunity and may even be pathogenic. Thus, the factors
that regulate the polarization to either a Th1 or Th2 im-
mune response are critical, but remain unclear. The dose of
antigen and the type of APC, and/or the co-stimulatory
pathways (2–6), have been postulated to be some of the
polarizing factors. However, the most effective inducer of
CD4
 
1
 
 T cell differentiation appears to be the local cytokine
environment. It is clear that the cytokine IL-12 directs dif-
ferentiation to a Th1 phenotype (7, 8), while IL-4 can drive
differentiation to a Th2 phenotype (9, 10).
If cytokines are indeed the driving force behind CD4
 
1
 
 T
cell differentiation, where does the initial polarizing cyto-
kine come from? Several findings suggest that during the
initiation of a Th1 response, IL-12 is produced particularly
by macrophages in response to certain microbial antigens,
while NK cells are the main source of IFN-
 
g
 
 in response to
IL-12 (7, 11). In the case of a Th2 response, the initial
source of IL-4 is less clear, since none of the classical APCs
make IL-4. Some non-APCs, such as mast cells and baso-
phils, can produce IL-4, but these cells are not abundant in
the lymphoid organs where T cell priming occurs (12).
Recently, it has been shown that IL-4 is also produced by a
minor subpopulation of T cells, the CD3
 
1
 
CD4
 
1
 
NK1.1
 
1
 
cells, which may therefore have a role (13). However, the
production of IL-4 by mast cells and basophils is a late
event and it is not yet clear how the CD4
 
1
 
NK1.1
 
1
 
 cells
become activated. An alternative possibility, however, is
that other cytokines may induce the initial production of
IL-4 by the CD4
 
1
 
 T cells; after this initial stimulus, the se-
creted IL-4 could act in an autocrine fashion, upregulating
IL-4 production and inhibiting IFN-
 
g
 
 production, thereby
polarizing the differentiation of Th2 cells.
In an attempt to find potential cytokines that, like IL-12,
could be produced by classical APCs and could trigger the
initial IL-4 production by CD4
 
1
 
 T cells, we analyzed the
modulatory effects of IL-6, a cytokine involved in different
aspects of the immune response and acute phase response
(for review see references 14 and 15). Here we show that
IL-6 is able to initiate the polarization of naive CD4
 
1
 
 T cells
to effector Th2 cells by inducing the production of endog-
enous IL-4. In addition, IL-6 also antagonizes the IL-12–
mediated differentiation of Th1 cells. We postulate that IL-6
is a key factor in the choice between a Th1 or Th2 im-
mune response.
 
Materials and Methods
 
Cell Preparation and Reagents.
 
Total CD4
 
1
 
 T cells were iso-
lated from spleen and lymph nodes from either wild-type B10.BR,
wild-type C57BL/6J, or C57BL/6J-backcrossed IL-6–deficient
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mice by negative selection as previously described (16). The naive
population (CD4
 
1
 
CD45RB
 
high
 
CD44
 
low
 
) was purified from total
CD4
 
1
 
 T cells obtained from cytochrome (Cyt)
 
1
 
 c TCR trans-
genic mice by staining with a red
 
613
 
-conjugated anti-CD4 mAb, a
biotinylated anti-CD44 mAb, FITC-conjugated anti-CD45RB
mAb,  and PE-conjugated streptavidin (PharMingen, San Diego,
CA) and cell sorting by using a FACS
 
PLUS
 
Ò
 
. Mitomycin C-treated
(50 
 
m
 
g/ml) syngeneic splenocytes were used as source of APCs.
Total or naive CD4
 
1
 
 T cells were cultured at 10
 
6
 
 cells/ml in
the presence of syngeneic APCs (5 
 
3
 
 10
 
5
 
 cells/ml) with Con A
(Boehringer Mannheim GmbH, Mannheim, Germany) or syn-
thetic moth Cyt c peptide (Yale University, New Haven, CT)
plus IL-6 (R&D Sys., Inc., Minneapolis, MN), IL-12 (provided
by Genetics Institute, Cambridge, MA), or IL-4 (provided by
DNAX, Palo Alto, CA). After 4 d, a 40–60% increase in the num-
ber of cells was observed in the different conditions. Effector Th
cells were exhaustively washed, counted, and restimulated at 10
 
6
 
cells/ml with Con A (in the absence of APCs) or Cyt c peptide
plus APCs (5 
 
3
 
 10
 
5
 
 cells/ml). Anti-CD3 mAb (2C11) was im-
mobilized on plastic at 5 
 
m
 
g/ml and anti-CD28 (PharMingen)
was used in a soluble form (1 
 
m
 
g/ml).
 
Cell Surface Staining.
 
Expression of IL-6R
 
a
 
 was analyzed by
FACS
 
Ò
 
 by double staining with a FITC-conjugated anti-CD4
mAb and a biotinylated anti–IL-6R
 
a
 
 mAb (PharMingen) in
combination with PE-conjugated streptavidin.
 
Competitive Reverse Transcriptase-PCR.
 
Total RNA was ex-
tracted as described (17) from 2 
 
3
 
 10
 
5
 
 cells mixed with 10
 
4
 
 Raji
cells which were added at harvest as an internal control, and the
amount of human MHC class II HLA-DR cDNA from Raji cells
was used as an internal standard. In brief, after dilution (1/2) of re-
verse transcription reaction mixture, 5 
 
m
 
l was assayed for levels of
DR cDNA by PCR using DR-specific primers in the presence of
DR competitor construct (50 pg) to confirm the efficiency of RNA
extraction and reverse transcriptase (RT)-PCR procedure in each
group. IL-4 transcript levels in the 5 
 
m
 
l of diluted (1/2) reverse tran-
scription reaction mixture was semi-quantitated using the competitor
(167 fg) in the presence of specific primers as described (18). DR
primers used were (5
 
9
 
-CGAGTTCTATACTGAATCCTG, and
3
 
9
 
-GTTCTGCTGCATTGCTTTTGC). Competitor amounts
shown  (competition cDNA, fg or pg) are corrected to represent the
amount of IL-4 or DR gene and not as the total plasmid amount. A
multiple cytokine-containing competitor construct was a gift from
R.M. Locksley (University of California, San Francisco, CA).
 
Cytokine Production.
 
ELISA assays were performed using pu-
rified anti–IL-4, anti–IL-12, and anti–IL-6 mAbs (3 
 
m
 
g/ml) as
primary antibodies, the corresponding biotinylated anti–IL-4,
anti–IL-12 and anti–IL-6 mAbs (1 
 
m
 
g/ml; PharMingen), and
horseradish peroxidase-conjugated avidin D (2.5 
 
m
 
g/ml) (Vector
Labs., Inc., Burlingame, CA), the TMB microwell peroxidase
substrate  and stop solution (Kirkegaard & Perry Labs., Inc., Gaithers-
burg, MD), using the recommended protocol (PharMingen). Re-
combinant IL-4 (DNAX) and IFN-
 
g
 
 (GIBCO BRL, Gaithers-
burg, MD) were used as standards. The specific activity of the IL-4
 
1
 
Abbreviations used in this paper:
 
 Cyt, cytochrome; NFAT, nuclear factor of
activated T cells; RT, reverse transcriptase; WT, wild type. 
463
 
Rincón et al.
and the IFN-
 
g
 
 that were used as standards for the ELISA assays
were 10
 
8
 
 U/mg for IL-4 and 10
 
7
 
 U/mg for IFN-
 
g
 
.
 
Results and Discussion
 
IL-6 is produced by a wide spectrum of cells including
fibroblasts, endothelial cells, neuronal cells, macrophages,
mast cells, tumor cell lines, and CD4
 
1
 
 Th2 cells, but from
an immunological point of view, APCs represent the major
source of IL-6 (14, 19). To determine the potential role of
IL-6 in differentiation of naive CD4
 
1
 
 T cells into effector
Th1 and Th2 cells, we first analyzed the effect of exoge-
nous IL-6. Total mouse CD4
 
1
 
 T cells were isolated (16)
and stimulated to differentiate with Con A with or without
IL-4 (Th2) or IL-12 (Th1) in the presence or absence of
exogenous IL-6. After 4 d, the effector Th1 or Th2 cells
were exhaustively washed, counted, and equal number of
cells were restimulated with Con A for 24 h before harvest-
ing the supernatant which was then analyzed for cytokine
production. Interestingly, even in the absence of any polar-
izing cytokine, IL-6 directed the differentiation of the
CD4
 
1
 
 cells to a Th2 phenotype, since the cells produce
high amounts of IL-4, but not IFN-
 
g
 
 (Fig. 1 
 
A
 
). IL-6 did
not modify the differentiation of the Th2 cells directed by
IL-4. However, differentiation into Th1 cells by IL-12,
was impaired in the presence of IL-6. Thus, Th1 cells dif-
ferentiated with Con A and IL-12 in the presence of IL-6,
produced less IFN-
 
g
 
, and more IL-4 (Fig. 1 
 
A
 
). IL-6, like
IL-2, has been described to be a growth factor for a num-
ber of cells (14, 15). However, only IL-6, but not IL-2, was
able to modify the polarization of the CD4
 
1
 
 cells to Th2
phenotype (Fig. 1 
 
A
 
), indicating that IL-6 is involved in
differentiation rather than growth of T cells. To eliminate
the possibility that IL-6 could favor the expansion or IL-4
secretion of the CD4
 
1
 
 memory subpopulation, which has
been described to display a Th2 phenotype (20), we ana-
lyzed the role of IL-6 in the differentiation of purified na-
ive CD4
 
1
 
 T cells. Thus, we used CD4
 
1
 
 T cells from TCR
transgenic mice (21), which express the 
 
a
 
 and 
 
b
 
 chain of
the TCR that recognizes a pigeon Cyt c peptide; before
further purification, 90–95% of the CD4
 
1
 
 T cells express
the naive phenotype. Total CD4
 
1
 
 T cells were stained with
anti-CD44 and anti-CD45RB mAbs and the naive CD4
 
1
 
CD44
 
low
 
CD45RB
 
high
 
 population was isolated by cell sort-
Figure 1. IL-6 directs differentiation of CD41 T cells into Th2 cells. (A) Total
CD41 T cells (106/ml) were purified from normal B10.BR mice and stimulated (in
the presence of 5 3 105 cell/ml syngeneic APCs) with Con A (2.5 mg/ml) alone,
Con A plus IL-4 (103 U/ml) or Con A plus IL-12 (3.5 ng/ml), in the absence (2) or
presence of IL-6 (100 ng/ml) or IL-2 (50 U/ml). After 4 d, cells were exhaustively
washed and restimulated (106 cells/ml) with Con A alone (2.5 mg/ml) in the absence
of APCs or additional cytokines. Supernatants were harvested 24 h later and analyzed
for IL-4 and IFN-g production by ELISA. (B) Total CD41 population was isolated
from Cyt c TCR transgenic mice, and the naive CD41 CD45RBhighCD44low subpop-
ulation was purified by cell sorting. Naive CD41 T cells were then stimulated with
Con A alone, Con A plus IL-4, or Con A plus IL-12, and APCs, in the presence or
absence of IL-6. After 4 d, cells were exhaustively washed and restimulated (106 cell/
ml) with Con A alone for 24 h before harvesting the supernatants for cytokine mea-
surement. (C) Naive CD41CD45RBhighCD44low CD41 T cells isolated from Cyt c
TCR transgenic mice were stimulated with Cyt c peptide and APCs, in the presence
of medium, IL-6 (100 ng/ml), or IL-4, (103 U/ml). After 4 d, cells were exhaustively
washed and restimulated (106 cell/ml) with Cyt c peptide and APCs for 24 h. (D) To-
tal CD41 T cells from normal B10.BR mice were stimulated with immobilized anti–
CD3 mAb (5 mg/ml) and soluble anti–CD28 (1 mg/ml) in the presence of medium
(2), IL-6 (100 ng/ml), or IL-4 (103 U/ml) and, after 4 d, they were restimulated
with immobilized anti–CD3 mAb. (E) Total CD41 T cells from normal B10.BR mice were stimulated with Con A and APCs in the presence of me-
dium (2), IL-6 (100 ng/ml) (IL-6), or IL-6 (100 ng/ml) plus anti–IL-4 mAb (10 mg/ml) (IL-6 1 anti–IL-4), for 4 d. Cells were then restimulated (106
cells/ml) with Con A alone as described in A.464 IL-6 Directs the Differentiation of IL-4–producing CD41 T Cells
ing and activated with the same polyclonal stimulus, Con A,
in the presence or absence of different cytokines. We ob-
served that IL-6, in the absence of any other cytokine, was
able to promote the differentiation of naive CD41 cells to
IL-4–producing cells (Fig. 1 B). In addition, we also ana-
lyzed the effect of IL-6 in the differentiation of naive
CD41 T cells stimulated by specific antigen. The presence
of IL-6 during the activation with Cyt c peptide drove dif-
ferentiation of naive CD41 T cells into IL-4–producing ef-
fector Th2 cells as well or better than IL-4 (Fig. 1 C).
Therefore, the modulatory effect of IL-6 in T cell differen-
tiation is not a consequence of an expansion of the memory
subpopulation.
Other cytokines have also been described to indirectly
modulate the polarization towards Th1 and Th2. IL-10, a
Th2 cytokine, promotes Th2 and inhibits Th1 cells, their
cytokines, and related immune phenomena. Although the
mechanism is not clear yet, several lines of evidence indi-
cate that IL-10 reduces the Th1 response by an inhibitory
effect on the IL-12 expression by APCs such as macrophages
(22–24). In contrast, the immunoregulatory role of IL-6 in
the polarization of Th1 and Th2 is not an indirect effect on
the APCs. Thus, IL-6 inhibited IFN-g production and
stimulated IL-4 synthesis by Th1 cells that have been dif-
ferentiated in the presence of exogenous IL-12 (Fig. 1, A
and B), eliminating the possibility of inhibiting the produc-
tion of IL-12 by APCs. In addition, IL-6 did not affect the
expression on the APCs of co-stimulatory molecules such
as B7.1 and B7.1, which have also been involved in the dif-
ferentiation of Th1 and Th2 cells (5, 6; data not shown).
To further prove that the effect of IL-6 was on T cells di-
rectly, rather than APCs, we differentiated CD41 T cells
with immobilized anti-CD3 mAb plus anti-CD28 mAb in
the complete absence of APCs, and then restimulated these
cells with anti-CD3 mAb alone. The presence of IL-6 (or
IL-4 as a control) during the first culture resulted in an in-
crease of IL-4 production and a dramatic reduction of IFN-g
production (Fig. 1 D) by the cells that were elicited, show-
ing that IL-6 directly favors the polarization of naive CD41
T cells to Th2 cells via the T cell.
IL-4 is the most effective differentiation factor for Th2
cells; it acts by promoting the secretion of more IL-4 and
inhibiting the production of IFN-g by T cells (9, 10). It
was therefore possible that IL-6 could directly upregulate
the synthesis of IL-4 by T cells and, consequently, that the
IL-6 effect was mediated through IL-4, which would be
responsible for the suppression of Th1 differentiation, while
favoring a Th2 response. To address this hypothesis, CD41
T cells were differentiated with Con A and IL-6 in the
presence or absence of neutralizing anti–IL-4 mAb, and af-
ter 4 d, the cells were washed and restimulated with Con A.
The ability of IL-6 to polarize CD41 T cells toward the
Th2 phenotype was blocked by anti–IL-4 mAbs, since the
cells were unable to produce IL-4 upon restimulation (Fig.
1 E). These results indicated that the differentiation of Th2
cells by IL-6 is dependent on the endogenous production
of IL-4. It was therefore possible that IL-6 may trigger the
Th2 pathway by inducing small amounts of IL-4, which in
turn would act as an autocrine differentiation factor for the
Th2 cells.
As mentioned above, APCs represent the major source
of IL-6 early in the immune response. To examine the
physiological role of IL-6 in T cell differentiation, we first
measured the production of IL-6 during the differentiation
of Th1 and Th2 cells. CD41 T cells were stimulated with
Con A and IL-4 or IL-12 in the presence of APCs, and su-
pernatants were harvested after different periods of time to
measure IL-6 secretion. After 2 d of culture, identical levels
of IL-6 were detected in the IL-4 and IL-12 cultures (Fig.
2 A). However, while the IL-6 level in the presence of
IL-12 was sustained during the course of T cell differentia-
tion, it decayed dramatically during the differentiation of
Th2 cells in the presence of IL-4. No IL-6 was detected af-
ter restimulation of either Th1 or Th2 cells with Con A in
the absence of APCs (data not shown), suggesting that the
IL-6 that we detected during the first stimulation was se-
creted mainly by the APCs. The difference in the kinetics
of IL-6 synthesis during the differentiation of Th1 and Th2
could, therefore, be due either to upregulation of IL-6 on
the APCs in the presence of IL-12, or greater IL-6 con-
sumption by Th2 cells than by Th1 cells. To test this, we
examined IL-6 production during the differentiation of
Th1 and Th2 in the presence of an anti–IL-6 receptor (IL-6R)
mAb, to block IL-6 consumption. In the presence of anti–
IL-6R mAb IL-6 did not diminish during the differentia-
tion of Th2 cells (Fig. 2 B). These data indicate that the IL-6
produced by APCs was consumed during the differentia-
tion of Th2 cells, but not during differentiation of Th1
cells, supporting the idea that IL-6 plays a role during Th2
polarization by acting directly on T cells. IL-6R is a het-
erodimer of the signal transducer gp130 (which is also a
component of the IL-11, ciliary neurotrophic factor, leuke-
mia inhibitory factor, and onconstatin M receptors) and the
specific IL-6Ra chain (25–30). IL-6R has been found in
both unstimulated CD41 and CD81 T cell subsets and its
expression is downregulated upon activation (31). Differ-
ential expression of the IL-6Ra chain during Th1 or Th2
differentiation could explain the higher IL-6 consumption
by the Th2 cells. We also analyzed, therefore, the expres-
sion of IL-6Ra during the differentiation of CD41 T cells
in effector Th1 or Th2 cells. However, the expression of
cell surface IL-6Ra was regulated similarly during the dif-
ferentiation of Th1 or Th2 cells in the presence of either
IL-4 or -12 (Fig. 2 C). Low levels of IL-6Ra were present
on unstimulated CD41 T cells, and downmodulation oc-
curred after the first day of stimulation, remaining at almost
undetectable levels during the differentiation of both Th1
and Th2 cells. These results indicated that the effects of IL-6
in the differentiation of Th2 cells were not due to a differ-
ential distribution of the IL-6Ra.
If IL-6 was required for Th2 cell differentiation in vitro,
it would follow that T cells from IL-62/2 mice should be
incapable of developing Th2 effector cells. The experi-
ments described below show that this appears to be true. In
correlation with the previous characterization of IL-62/2
mice (32, 33), analysis of cellular populations in the spleen465 Rincón et al.
and thymus did not show any differences between wild-
type (WT) and IL-62/2 mice (data not shown), and IL-62/2
mice developed normally. We therefore used splenocytes
from IL-62/2 mice as APCs to further establish that the
production of endogenous IL-6 by the APC plays a critical
role in the polarization of the CD41 T cells to effector Th2
cells. We purified CD41 T cells from WT mice and stimu-
lated them for 4 d with Con A in the presence of APCs
from WT mice or IL-62/2 mice in the absence of any
added exogenous cytokines. Restimulation with Con A re-
sulted in significantly less IL-4 production in cells differen-
tiated in the presence of IL-62/2 than in WT APCs (Fig.
3 A). Although the production of IFN-g under these con-
ditions (absence of exogenous IL-12) was low, the levels of
IFN-g produced by CD4 cells differentiated in the pres-
ence of IL-62/2 APCs were higher than those produced
by cells stimulated in the presence of WT APCs (data not
shown).
In vivo experiments have showed an impaired immune
response in IL-62/2 mice. These mice fail to control infec-
tion with Listeria monocytogenes and have a diminished T cell–
dependent body response against vesicular stomatitis virus
(32–34). In addition, CD41 cells from WT mice infected
with Candida albicans express IL-4, but reduced IgE and IL-4
mRNA was observed in IL-62/2 mice (35). Nevertheless,
due to the numerous effects of IL-6 in vivo, it is difficult to
study by which mechanism IL-6 affects the immunopathol-
ogy of infection and whether this is mediated by a modifi-
cation in T cell differentiation. We examined, therefore,
the in vitro differentiation of CD41 T cells from IL-6–defi-
cient mice. IL-62/2 CD41 T cells stimulated with Con A
in the presence of WT APCs, which can provide the IL-6
required, produced IL-4, but this IL-4 production was im-
paired when the IL-6 pathway was blocked by the addition
of anti–IL-6 mAbs (Fig. 3 B). Most significantly, however,
was that in the complete absence of IL-6, when IL-62/2
CD41 T cells were stimulated in the presence of IL-62/2
APCs, no in vitro Th2 response was obtained (Fig. 3 B).
The difference between complete absence of IL-4 produc-
tion when IL-62/2 APCs were used with IL-62/2 T cells
compared with IL-62/2 APCs and WT T cells may have
been the result of either IL-6 production from contaminat-
ing WT APCs in the T cells or a contribution of IL-6 from
the WT T cells. Moreover, high IL-4 production was re-
stored in cells that were differentiated in the presence of
IL-62/2 APCs together with an exogenous source of IL-6
(Fig. 3 B). Similar levels of IL-4 were detected when
CD41 T cells were differentiated in the presence of IL-4,
and no significant additional increase was observed when
both IL-4 and IL-6 were present during the differentiation,
indicating again that both IL-4 and IL-6 were using the
same pathway.
To demonstrate whether the upregulation of IL-4 pro-
duction by IL-6 was due to an induction of IL-4 gene ex-
pression rather than a posttranslational mechanism, e.g., in-
creasing IL-4 secretion, we examined the levels of IL-4
Figure 2. Regulation of IL-6
secretion by APCs during the
differentiation of Th1 and Th2
CD41 T cells. (A) Total CD41
T cells (B10.BR) were stimu-
lated with Con A (2.5 mg/ml)
plus IL-4 (103 U/ml) or IL-12
(3.5 ng/ml) in the presence of
APCs. Supernatants were har-
vested at different times of stim-
ulation (day 2, 3, or 4) and IL-6
secretion was analyzed. (B) Total
CD41 T cells were stimulated as
described in A, but in the pres-
ence of anti–IL-6Ra chain mAb
(10 mg/ml). The arrow indicates
the production of IL-6 after 4 d
of stimulation with Con A and
IL-4, in the absence of anti–IL-
6Ra mAb. (C) Expression of IL-
6Ra during the differentiation
of Th1 and Th2 cells. CD41 T
cells unstimulated (day 0) or
stimulated in the presence of
APCs, with Con A plus IL-4
(Con A/IL-4) or IL-12 (Con A/
IL-12) for different periods of
time (day 1, 2, or 4) were har-
vested, stained with anti-CD4
and anti–IL-6Ra mAbs, and an-
alyzed by FACSÒ. Fluorescence
profiles show the expression of
IL-6Ra in the CD41 popula-
tion.466 IL-6 Directs the Differentiation of IL-4–producing CD41 T Cells
mRNA. Naive CD41 T cells were isolated from Cyt c
TCR transgenic mice (see above) and stimulated with spe-
cific Cyt c peptide in the absence or presence of IL-6 or
IL-4. After 4 d, cells were washed and restimulated with
Cyt c peptide, and total RNA was isolated 20 h later. The
expression of the IL-4 gene was determined by competitive
RT-PCR of IL-4–specific transcripts (18). The presence of
exogenous IL-6 or IL-4 during the differentiation (Th2
cells) resulted in the induction of high levels of IL-4
mRNA upon antigen restimulation (Fig. 3 C). Quantita-
tion of IL-4 transcripts in cells differentiated in the presence
of IL-6 or IL-4 were 100-fold higher than in the absence of
cytokines (data not shown). Together, these data indicate
that IL-6 causes the differentiation of Th2 cells by upregu-
lating IL-4 gene expression. The transcriptional regulation
of the IL-4 gene has not yet been characterized as exten-
sively as the regulation of the IL-2 gene. Several positive
and negative regulatory elements in the 59 flanking region of
the IL-4 gene have been described (36–39). Among five
different nuclear factor of activated T cells (NFAT) binding
elements, one located between 290 and 260 is important
for the activation of the IL-4 gene expression. Like the dis-
tal NFAT site in the IL-2 promoter (40–42), this element
binds NFAT (either NFATp or NFATc) in association
with AP-1 components (37, 43). In addition, recently three
functional binding sites for the C/EBP family of transcrip-
tional factors have been identified in the IL-4 promoter (44),
which might be regulated by IL-6 since members of this
family (NF-IL6) have already been described as having been
activated by IL-6 in other systems (45–50). Whether IL-6
acts through these sites will be the subject of future studies.
Both in vivo and in vitro experiments support the idea
Figure 3. IL-6–producing APCs are required for the differentiation of
Th2 cells. (A) Total CD41 T cells (106/ml) were isolated from WT mice
and stimulated with Con A (2.5 mg/ml) alone in the presence of APCs (5 3
105 cells/ml) from WT (WT APC) or IL-6–deficient (IL-62/2 APC)
mice. After 4 d, CD41 T cells were washed and restimulated (106 cells/ml)
with Con A in the absence of APCs, and supernatants were collected after
24 h. (B) Total CD41 T cells were isolated from IL-6–deficient (IL-62/2)
mice and stimulated with Con A plus medium (2), neutralizing anti–IL-6
mAb (10 mg/ml) (anti–IL-6), IL-6 (100 ng/ml), IL-4 (103 U/ml), or both
(IL-4 1 IL-6), in the presence of APCs from WT (WT APC) or IL-6–
deficient (IL-62/2) mice. After 4 d, cells were washed and restimulated
(106 cells/ml) with Con A alone for 24 h. Only in the case where all cells
(both CD4 T cells and APCs) were from IL-62/2 mice did we observe a
slightly lower recovery (70–80% of the recovery from other conditions)
after 4 d of primary culture. Nevertheless, cell number was normalized
(106 cells/ml) before restimulation. (C) Induction of IL-4 gene expression in CD41 Th2 cells differentiated in the presence of IL-6. Naive CD41 T
cells (12) from Cyt c TCR transgenic mice were primary cultured with moth Cyt c peptide (5 mg/ml) and APCs in the absence (2) or the presence of
IL-6 (100 ng/ml) or IL-4 (103 U/ml) for 4 d. Cells were then washed and stimulated with Cyt c peptide and APCs. After 20 h, 2 3 105 cells were har-
vested and used for the quantitation of IL-4 mRNA by competitive RT-PCR. (Top) The expression of IL-4 transcripts. (Bottom) The expression of DR
transcripts. Small arrow, the competitor DNA.467 Rincón et al.
that, although other factors can play immunomodulatory
roles, IL-4 and IL-12 are both necessary and sufficient for
the polarization of Th1 and Th2 during the response to dif-
ferent pathogens. Considerable interest in the initial source
of the IL-4 that drives Th2 cell differentiation has been ex-
pressed and recent attention has focused on mast cells or
NK1.11 CD4 T cells. We propose here that IL-6 is one of
the stimuli in the initial production of IL-4 which provides
a new mechanism to initiate Th2 CD41 T cell differentia-
tion. The levels of IL-6 that we used in these experiments
are relatively high, just as the levels of IL-4 that also must
be used to direct Th2 differentiation in vitro are (500–
1,000 U/ml IL-4). Presumably, for both IL-4 and IL-6
produced endogenously, lower levels produced in a local
microenvironment suffice. Consistent with this idea, al-
though the IL-6 effect is mediated through IL-4 (since it is
blocked by anti–IL-4), the levels of IL-4 that can be de-
tected are very low, presumably because of local consump-
tion, but are sufficient to direct Th2 cell differentiation.
Our data suggest a model (Fig. 4) for Th2 differentiation
that is strikingly similar to the mechanism used for Th1 dif-
ferentiation. In both cases, the source of the polarizing cy-
tokine is the APC, IL-12 in the case of Th1 cells and IL-6
in the case of Th2 cells. Although APCs are the major
source of IL-6 in vitro, other cell types that produce IL-6,
such as fibroblasts, endothelial cells, keratinocytes or others,
could also contribute to the overall in vivo IL-6 produc-
tion. In our in vitro model, activation of the APC is pro-
posed to result in the secretion of IL-6 which, in combina-
tion with the antigen, will participate in the induction of
IL-4 gene expression in naive CD41 T cells. In the second
step, the low levels of IL-4 secreted by the T cells is suffi-
cient to induce upregulation of the IL-4 and IL-4 receptor
genes in an autocrine manner, while it inhibits the expres-
sion of the IFN-g gene. Cells are therefore subsequently po-
larized to a Th2 phenotype using their own source of IL-4.
Figure 4. Schematic model for the differentiation of precursors Th cells (pTh) into effector Th1 and Th2 cells.
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